Alliance Global Partners initiates research coverage of Incannex with BUY rating
Alliance Global Partners has initiated equity research coverage of Incannex Healthcare with a BUY rating and $18.00 price target, authored by analyst James Molloy. The coverage highlights the company's clinical pipeline including IHL-42X for obstructive sleep apnea and PSX-001 for generalized anxiety disorder.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day